The price of Cosmos (ATOM) has shown support around the $4.00 area in June, trading between $3.98 and $4.09 after moving above nearby resistance on June 20 and June 23. Some market watchers have pointed to resistance near $4.08, describing the move as a consolidation phase after higher-volume trading. The article also references Qubetics ($TICS), which the project says is focused on interoperability and business-oriented tooling.
Qubetics says it aims to support interoperability across networks such as Bitcoin, Ethereum and Solana, alongside services it describes as dVPN-related, with the goal of supporting cross-network workflows. The project has also stated that it plans a centralized exchange (CEX) listing and has cited a target listing price of $0.40; this information should be treated as project-reported and subject to change. References to a token sale in this article are based on figures provided by the project.
Injective (INJ) has traded in a relatively steady range around $11.4 in the period referenced. Reported trading volumes around $150 million and a weekly gain of roughly 5% were cited by the source text; as with all market data, figures vary by venue and time. Any price outlooks mentioned by commentators remain speculative and uncertain.
Qubetics: Interoperability claims and token sale updates
According to project materials, Qubetics is positioned around interoperability, including bridging activity across several networks. The project describes a protocol intended to connect Bitcoin, Ethereum, Solana and other decentralized platforms.
The same materials describe cross-network transactions, smart-contract deployment and asset management without relying on a single chain. The project also states it is intended to integrate with Web3 wallets, enterprise tools and blockchain-based services.
Token sale stage details & supply changes (project-reported)
The project says it has advanced to Stage 37 of its crypto presale and lists a token sale price of $0.3370, alongside a stated target listing price of $0.40. The article’s source text also cited fundraising totals (over $18.1 million), the number of tokens sold (more than 516 million $TICS), and a holder count (over 28,200). These figures have not been independently verified here.
The source text further stated that Qubetics reduced its total token supply from over 4 billion to 1.36 billion and increased the public sale allocation to 38.55%. Readers should treat such tokenomics information as project-reported and review primary documentation for the most up-to-date terms.
Planned exchange listing and security-related claims
Qubetics has said it expects a CEX listing and has referenced a $0.40 listing price. Exchange listings, pricing and timelines can change, and availability may differ by jurisdiction and platform.
The source text also referenced a CertiK audit and a reported code security score above 80%, as well as a $30,000 bug bounty program described as being promoted across developer communities. These statements should be verified through the relevant third-party and project channels.
Any discussion of potential price changes, returns or “locked-in” outcomes should be treated as speculative; token prices can move in either direction and may be volatile around listing events.
Injective (INJ) – DeFi infrastructure overview
Injective is often discussed in the context of decentralized finance infrastructure. Project documentation describes features such as derivatives markets and cross-chain functionality; any “zero-fee” claims may depend on the product, venue and network conditions. The source text cited INJ at $11.42 with a market cap of approximately $1.14 billion and a 24-hour volume near $155 million at the time referenced.
The article’s source text also referenced summer price ranges between $11.28 and $15. Forecasts are not guarantees and should not be treated as predictions of future performance.
Cosmos (ATOM) – Hub of interoperable chains
Cosmos is commonly referenced for its interoperability tooling. Recent price data cited in the source text described ATOM holding around the $4.00–$4.09 band, with attention on resistance near $4.08.
The source text stated that more than 100 Cosmos-based chains are active and referenced an upgrade aimed at stability and zone-to-zone messaging. It also noted growing utility across EVM-compatible zones and developer interest in interchain application interactions.
Final Thoughts
This article compares several topics raised in recent market commentary: Cosmos price levels and network upgrades, Injective’s DeFi positioning, and project-stated details about Qubetics’ interoperability focus and token sale. Readers should verify project claims and market statistics using primary sources and reputable data providers.
This article is for informational purposes only and does not constitute financial or investment advice.
This outlet is not affiliated with the project mentioned.
For More Information:
Qubetics (project website, for reference): https://qubetics.com
Token sale page (project link, for reference): https://buy.qubetics.com/
Twitter: https://x.com/qubetics
FAQs
- What does the Qubetics project claim to offer?
Project materials describe Qubetics as focused on cross-chain interoperability and tools intended for transactions and applications across multiple networks. These claims should be reviewed against primary documentation. - What information was cited about Injective in this article?
The source text referenced Injective’s DeFi positioning, recent trading activity, and a market range around $11–$12 at the time cited, alongside speculative price ranges published by commentators. - What was highlighted about Cosmos?
The article referenced Cosmos’ interoperability focus, recent ATOM price levels around $4, and network upgrades aimed at messaging between zones. - What was said about the Qubetics token sale structure?
The source text stated the token sale spans 37 stages and that Stage 37 is described as the final phase, with a stated price of $0.3370 and a project-cited target listing price of $0.40. Readers should confirm terms directly with the project and understand that market pricing is not guaranteed.
5. What security measures were mentioned?
According to the source text, Qubetics referenced a CertiK audit score above 80% and a $30,000 bug bounty program; these details should be verified via the relevant public sources.
Summary:
This article reviews recent references to Cosmos (ATOM) price levels and network updates, Injective (INJ) market activity and DeFi positioning, and project-stated claims about Qubetics’ interoperability focus, token sale and planned exchange listing. Any forecasts or return-related statements are speculative and uncertain, and readers should validate project-provided figures independently.
Press releases or guest posts published by Crypto Economy have been submitted by companies or their representatives. Crypto Economy is not part of any of these agencies, projects or platforms. At Crypto Economy we do not give investment advice, if you are going to invest in any of the promoted projects you should do your own research.
